Pilot Extension for Individual Patient Input to CDR
We are further extending the pilot to receive patient input submissions from individual patients and caregivers for an additional six months (until August 3, 2015).
CADTH will accept patient input from individual patients or caregivers when there is no patient group or related patient group rep...
Nominations are now being accepted for two prestigious awards for outstanding achievement in the field of health technology assessment (HTA) in Canada.
The Dr. Jill M. Sanders Award of Excellence in Health Technology Assessment recognizes individuals whose outstanding achievements have significantly advanced the field of HTA in Canada.
Short Videos on Patient Input into the CADTH Common Drug Review
CADTH recently produced four short videos describing:
why CADTH values patient input
what elements are most useful to reviewers and expert committee members in groups' patient input submissions
how to submit input.
Canadian Drug Expert Committee Public Member, Frank Gavin and former...
Technical difficulties resolved for patient input submissions
We’ve had a few technical problems recently with our Common Drug Review patient input online submission system. Thank you for your patience and understanding while we investigated and fixed the problem. We’ve added new safeguards to enable us to closer track submissions into our auto...
Wednesday, September 10, 2014, Ottawa — Dr. Brian O’Rourke, President and CEO of CADTH, today announced the appointment of three new core members to the Health Technology Expert Review Panel:
Jenny Basran, MD, FRCPC — Internist Geriatrician and Associate Professor in the Department of Medicine at the University of Saskatchewan
Leslie Anne Campbe...